Evidence map›Paper›PMID 24102106›Full record

ReviewBritish journal of pharmacology2014

The role of ATP-sensitive potassium channels in cellular function and protection in the cardiovascular system.

Andrew Tinker, Qadeer Aziz, Alison Thomas

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 110 citations in OpenAlex.

  1. Article
  2. Article
  3. Acute Hypoxia Inhibits KActa physiologica (Oxford, England) · 2026
    Article
  4. Article
  5. Pharmaceutical agents targeting KThe journal of physiological sciences : JPS · 2026
    Article
  6. Adaptations to hypoxia in the vertebrate retina.The Journal of physiology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Signaling Paradigms of HAntioxidants (Basel, Switzerland) · 2024
    Review
  11. Review
  12. Article
  13. KArhiv za farmaciju · 2024
    Article
  14. Article
  15. Non-radioactive RbMethods in molecular biology (Clifton, N.J.) · 2024
    Article
  16. Article
  17. Review
  18. The ATP-dependent Pathways and Human Diseases.Current medicinal chemistry · 2023
    Article
  19. Kir6.1 and SUR2B in Cantú syndrome.American journal of physiology. Cell physiology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrew TinkerWilliam Harvey Heart Centre, Barts and The London School of Medicine and Dentistry, London, UK.
Qadeer Aziz
Alison Thomas
William Harvey Research Institute · GB

Funding

British Heart Foundation RG/10/10/28447Medical Research CouncilWellcome Trust
6 · The paper itself

Abstract

ATP-sensitive potassium channels (K(ATP)) are widely distributed and present in a number of tissues including muscle, pancreatic beta cells and the brain. Their activity is regulated by adenine nucleotides, characteristically being activated by falling ATP and rising ADP levels. Thus, they link cellular metabolism with membrane excitability. Recent studies using genetically modified mice and genomic studies in patients have implicated K(ATP) channels in a number of physiological and pathological processes. In this review, we focus on their role in cellular function and protection particularly in the cardiovascular system.

Indexed as

Signal TransductionAnimalsCardiovascular DiseasesCardiovascular SystemHumansKATP ChannelsPotassium ChannelsKATP Channelsmitochondrial K(ATP) channelPotassium ChannelsATP-sensitive potassium channelcardiac myocytepathophysiologyphysiologysmooth muscle

Identifiers

PMID24102106
PMCPMC3874693
OpenAlexW1575190123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.